Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).
Pizarro D, Romero I, Pérez-Mies B, Redondo A, Caniego-Casas T, Carretero-Barrio I, Cristóbal E, Gutiérrez-Pecharromán A, Santaballa A, D'Angelo E, Hardisson D, Vieites B, Matías-Guiu X, Estévez P, Guerra E, Prat J, Poveda A, López-Guerrero JA, Palacios J. Pizarro D, et al. Among authors: santaballa a. Int J Mol Sci. 2023 Jul 6;24(13):11183. doi: 10.3390/ijms241311183. Int J Mol Sci. 2023. PMID: 37446361 Free PMC article.
A phase 3 trial of bevacizumab in ovarian cancer.
Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM; ICON7 Investigators. Perren TJ, et al. N Engl J Med. 2011 Dec 29;365(26):2484-96. doi: 10.1056/NEJMoa1103799. N Engl J Med. 2011. PMID: 22204725 Free article. Clinical Trial.
SEOM Clinical Guideline in ovarian cancer (2016).
Santaballa A, Barretina P, Casado A, García Y, González-Martín A, Guerra E, Laínez N, Martinez J, Redondo A, Romero I. Santaballa A, et al. Clin Transl Oncol. 2016 Dec;18(12):1206-1212. doi: 10.1007/s12094-016-1588-8. Epub 2016 Nov 30. Clin Transl Oncol. 2016. PMID: 27905052 Free PMC article.
SEOM clinical guidelines for endometrial cancer (2017).
Santaballa A, Matías-Guiu X, Redondo A, Carballo N, Gil M, Gómez C, Gorostidi M, Gutierrez M, Gónzalez-Martín A. Santaballa A, et al. Clin Transl Oncol. 2018 Jan;20(1):29-37. doi: 10.1007/s12094-017-1809-9. Epub 2017 Dec 13. Clin Transl Oncol. 2018. PMID: 29238915 Free PMC article.
Correction to: SEOM clinical guidelines for endometrial cancer (2017).
Santaballa A, Matías-Guiu X, Redondo A, Carballo N, Gil M, Gómez C, Gorostidi M, Gutierrez M, Gónzalez-Martín A. Santaballa A, et al. Clin Transl Oncol. 2018 Apr;20(4):559-560. doi: 10.1007/s12094-018-1842-3. Clin Transl Oncol. 2018. PMID: 29417438 Free PMC article.
GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer.
Perez-Fidalgo JA, Iglesias M, Bohn U, Calvo E, Garcia Y, Guerra E, Manso L, Santaballa A, Gonzalez-Martin A. Perez-Fidalgo JA, et al. Among authors: santaballa a. Future Sci OA. 2019 Jan 10;5(2):FSO370. doi: 10.4155/fsoa-2018-0107. eCollection 2019 Feb. Future Sci OA. 2019. PMID: 30820349 Free PMC article. Review.
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.
Romero I, Mallol P, Santaballa A, Del Campo JM, Mori M, González-Santiago S, Casado A, Vicente D, Ortega E, Herrero A, Guerra E, Barretina-Ginesta P, Rubio MJ, Martínez A, Bover I, Vidal L, Arcusa Á, Martín L, García Y, González-Martín A. Romero I, et al. Among authors: santaballa a. Anticancer Drugs. 2019 Jul;30(6):628-635. doi: 10.1097/CAD.0000000000000794. Anticancer Drugs. 2019. PMID: 31008727
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study).
Perez-Fidalgo JA, Cortés A, Guerra E, García Y, Iglesias M, Bohn Sarmiento U, Calvo García E, Manso Sánchez L, Santaballa A, Oaknin A, Redondo A, Rubio MJ, González-Martín A. Perez-Fidalgo JA, et al. Among authors: santaballa a. ESMO Open. 2021 Aug;6(4):100212. doi: 10.1016/j.esmoop.2021.100212. Epub 2021 Jul 27. ESMO Open. 2021. PMID: 34329939 Free PMC article. Clinical Trial.
SEOM-GEICO clinical guidelines on endometrial cancer (2021).
Barretina-Ginesta MP, Quindós M, Alarcón JD, Esteban C, Gaba L, Gómez C, Fidalgo JAP, Romero I, Santaballa A, Rubio-Pérez MJ. Barretina-Ginesta MP, et al. Among authors: santaballa a. Clin Transl Oncol. 2022 Apr;24(4):625-634. doi: 10.1007/s12094-022-02799-7. Epub 2022 Mar 21. Clin Transl Oncol. 2022. PMID: 35312947 Free PMC article.
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.
Yubero A, Barquín A, Estévez P, Pajares B, Sánchez L, Reche P, Alarcón J, Calzas J, Gaba L, Fuentes J, Santaballa A, Salvador C, Manso L, Herrero A, Taus Á, Márquez R, Madani J, Merino M, Marquina G, Casado V, Constenla M, Gutiérrez M, Dosil A, González-Martín A. Yubero A, et al. Among authors: santaballa a. BMC Cancer. 2022 Nov 8;22(1):1150. doi: 10.1186/s12885-022-10191-5. BMC Cancer. 2022. PMID: 36348385 Free PMC article.
73 results